DarioHealth Reports Record Quarterly Revenues in its 2022 First Quarter
DarioHealth Corp. (DRIO)
NASDAQ:AMEX Investor Relations:
dariohealth.com/our-story
Company Research
Source: PR Newswire
Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021Accelerated Business-to-Business (B2B) transformation with 14 new B2B accounts in Q1 2022, including two health plans Expanded GAAP gross margin to 49.4% and non-GAAP gross margin to 61%Improved overall financial profile with increasing B2B revenue and reduced operating costs as B2B business matures resulting in a lower net loss compared to Q4 2021Company to host conference call and webcast 8:30 am ET todayNEW YORK, May 12, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the first quarter 2022 and provided a corporate and commercial update."Our first quarter results reflect our increasingly successful transition to a B2B model with growing revenue and gross margins," stated Erez Raphael, Chief Executive Officer of Dario. "We increased revenue nearly 124% over the fir
Show less
Read more
Impact Snapshot
Event Time:
DRIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRIO alerts
High impacting DarioHealth Corp. news events
Weekly update
A roundup of the hottest topics
DRIO
News
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 SolutionPR Newswire
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health [Yahoo! Finance]Yahoo! Finance
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral HealthPR Newswire
- Patient Empowerment Thematic Research Report 2024: Despite Increasing Technological Advancements, Physicians Still Play the Most Vital Role in Empowering Patients [Yahoo! Finance]Yahoo! Finance
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health [Yahoo! Finance]Yahoo! Finance
DRIO
Earnings
- 11/2/23 - Beat
DRIO
Sec Filings
- 4/5/24 - Form 8-K
- 3/28/24 - Form 10-K
- 3/8/24 - Form 4
- DRIO's page on the SEC website